Beta interferons and glatiramer acetate for treating multiple sclerosis

Equality Impact Assessment (Guidance development) (PDF 238 KB)

Final appraisal determination

Final appraisal determination document (PDF 529 KB)

Committee papers (PDF 1.8 MB)

Public committee slides (PDF 605 KB)

Draft guidance: 1

Appraisal consultation document (PDF 420 KB)

Committee papers (PDF 11.33 MB)

Public committee slides (PDF 626 KB)

Assessment report (PDF 4.54 MB)

Draft scope (post-referral) (PDF 93 KB)

Provisional matrix (post-referral) (PDF 92 KB)

Final scope (PDF 91 KB)

Final matrix (PDF 92 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 212 KB)

Equality impact assessment (Scoping) (PDF 77 KB)

Final protocol (PDF 234 KB)